Sign In
Buy PBYI
$6.81
-0.170 (-2.44%)
At Close: Jun 03, 2026
Why Shares of Puma Biotechnology Rose This Week
03:39pm, Thursday, 15'th Dec 2022
The company's CEO bought $2.5 million worth of company stock.
Puma Biotech (PBYI)'s Technical Outlook is Bright After Key Golden Cross
02:55pm, Monday, 28'th Nov 2022 Zacks Investment Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
Puma Biotech (PBYI)'s Technical Outlook is Bright After Key Golden Cross
11:17am, Monday, 28'th Nov 2022
Is it a good or bad thing when a stock experiences a golden cross technical event?
Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday
10:09am, Monday, 28'th Nov 2022 Benzinga
Gainers
AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share.
EUDA Health Holdings Limited (NASDAQ: EUDA) shares climbed 37% to c
Puma Biotechnology, Inc. (PBYI) Hits Fresh High: Is There Still Room to Run?
02:15pm, Tuesday, 22'nd Nov 2022 Zacks Investment Research
Puma Biotech (PBYI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
01:50pm, Tuesday, 22'nd Nov 2022 Zacks Investment Research
Puma Biotechnology (PBYI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
10:32am, Tuesday, 22'nd Nov 2022
Puma Biotechnology (PBYI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
08:49am, Tuesday, 22'nd Nov 2022 Benzinga
Gainers
Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
NeuroOne Medical Techn
Why Puma Biotechnology's Shares Jumped 20% on Monday
10:25pm, Monday, 21'st Nov 2022 The Motley Fool
It may have benefited from positive news about another company's drug candidate.
Why Puma Biotechnology's Shares Jumped 20% on Monday
05:25pm, Monday, 21'st Nov 2022
It may have benefited from positive news about another company's drug candidate.
Gilead (GILD) Outperforms YTD: Will It Retain the Momentum?
06:45pm, Friday, 18'th Nov 2022 Zacks Investment Research
Biotech giant Gilead (GILD) outperforms the industry and the S&P 500 Index as its core business maintains momentum despite volatility.
S&P 500 Down 1%; Crude Oil Drops Sharply
05:07pm, Thursday, 17'th Nov 2022 Benzinga
U.S. stocks traded lower midway through trading, with the S&P 500 dropping around 1% on Thursday.
The Dow traded down 0.53% to 33,377.30 while the NASDAQ fell 0.85% to 11,088.75. The S&P 500 also fell
Is Biogen (BIIB) a Great Value Stock Right Now?
02:40pm, Thursday, 17'th Nov 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Bayer (BAYRY) Eylea Label Extension Gets CHMP Positive Opinion
03:10pm, Monday, 14'th Nov 2022 Zacks Investment Research
Bayer (BAYRY) gets positive recommendation from the CHMP for label extension of ophthalmology drug Eylea for the treatment of preterm infants with retinopathy of prematurity.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
02:50pm, Monday, 14'th Nov 2022 Zacks Investment Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
